• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎的目标:靶向治疗还是预防治疗?

Goals for rheumatoid arthritis: treating to target or treating to prevent?

作者信息

Yang Min, Guo Mingyang

机构信息

Rheumatology Center, PLA General Hospital of Chengdu Military Area Command, Chengdu, Sichuan Province, PR China.

出版信息

Open Access Rheumatol. 2012 Jul 9;4:81-86. doi: 10.2147/OARRR.S32493. eCollection 2012.

DOI:10.2147/OARRR.S32493
PMID:27790015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5045102/
Abstract

Although treat-to-target goals for rheumatoid arthritis (RA) have been well-established through several guidelines in recent years, concerns regarding treat-to-prevent goals for RA remain unclear. RA patients are typically subjected to over- or under-treatment because it is difficult for clinicians to determine the prognosis of RA patients. This typically results in failure to select and identify patient subsets that should receive monotherapy or combination therapy to treat early RA. Understanding treat-to-prevent goals, as well as unfavorable prognoses, risk factors, and prediction methods for RA, is therefore critical for making treatment decisions. Rapid radiographic progression plays a central role in contributing to other composite RA indices, so this may be the best method for defining treat-to-prevent goals for RA. Accordingly, risk factors of rapid radiographic progression have been defined and two prediction models were retrospectively derived based on clinical trial data. Additional studies are required to develop risk models that can be used for accurate predictions.

摘要

尽管近年来通过多项指南已明确确立了类风湿关节炎(RA)的治疗达标目标,但对于RA的治疗预防目标仍不明确。RA患者通常会接受过度或不足的治疗,因为临床医生很难确定RA患者的预后。这通常导致无法选择和识别应接受单药治疗或联合治疗以治疗早期RA的患者亚组。因此,了解治疗预防目标以及RA的不良预后、危险因素和预测方法对于做出治疗决策至关重要。快速影像学进展在其他综合RA指标中起着核心作用,因此这可能是定义RA治疗预防目标的最佳方法。相应地,已确定了快速影像学进展的危险因素,并根据临床试验数据回顾性推导了两个预测模型。还需要进行更多研究来开发可用于准确预测的风险模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b84/5045102/8a28899cd8c5/oarrr-4-081Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b84/5045102/8a28899cd8c5/oarrr-4-081Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b84/5045102/8a28899cd8c5/oarrr-4-081Fig1.jpg

相似文献

1
Goals for rheumatoid arthritis: treating to target or treating to prevent?类风湿关节炎的目标:靶向治疗还是预防治疗?
Open Access Rheumatol. 2012 Jul 9;4:81-86. doi: 10.2147/OARRR.S32493. eCollection 2012.
2
A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.一种用于预测类风湿关节炎快速影像学进展的初步风险模型。
Rheumatology (Oxford). 2009 Sep;48(9):1114-21. doi: 10.1093/rheumatology/kep155. Epub 2009 Jul 9.
3
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis.生物制剂或托法替布用于生物制剂治疗类风湿关节炎失败的患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 Mar 10;3(3):CD012591. doi: 10.1002/14651858.CD012591.
4
Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.磁共振成像与常规达标治疗策略对类风湿关节炎疾病活动缓解和影像学进展的影响:IMAGINE-RA 随机临床试验。
JAMA. 2019 Feb 5;321(5):461-472. doi: 10.1001/jama.2018.21362.
5
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis.生物制剂或托法替布用于初治类风湿关节炎患者:一项系统评价和网状Meta分析
Cochrane Database Syst Rev. 2017 May 8;5(5):CD012657. doi: 10.1002/14651858.CD012657.
6
[Biologics and mycobacterial diseases].[生物制剂与分枝杆菌病]
Kekkaku. 2013 Mar;88(3):337-53.
7
The natural history and prognosis of rheumatoid arthritis: association of radiographic outcome with process variables, joint motion and immune proteins.类风湿关节炎的自然病史和预后:影像学结果与病程变量、关节活动及免疫蛋白的关联
Scand J Rheumatol Suppl. 2004;118:1-38. doi: 10.1080/03009740310004847.
8
Assessing prognosis and prediction of treatment response in early rheumatoid arthritis: systematic reviews.评估早期类风湿关节炎的预后和治疗反应预测:系统评价。
Health Technol Assess. 2018 Nov;22(66):1-294. doi: 10.3310/hta22660.
9
Efficacy of Tocilizumab Monotherapy Versus Tocilizumab and Methotrexate Combination Therapy in the Prevention of Radiographic Progression in Rheumatoid Arthritis: An Analysis Using Individual Patient Data From Multiple Clinical Trials.托珠单抗单药治疗与托珠单抗联合甲氨蝶呤治疗在预防类风湿关节炎影像学进展中的疗效:来自多项临床试验的个体患者数据分析。
Arthritis Care Res (Hoboken). 2022 Jun;74(6):889-895. doi: 10.1002/acr.24524. Epub 2022 Mar 25.
10
Clinical characteristics and variants that predict prognosis of difficult-to-treat rheumatoid arthritis.难以治疗的类风湿关节炎的临床特征和预测预后的变异。
Rheumatol Int. 2022 Nov;42(11):1947-1954. doi: 10.1007/s00296-022-05124-1. Epub 2022 Apr 11.

引用本文的文献

1
International multicenter randomized, placebo-controlled phase III clinical trial of β-D-mannuronic acid in rheumatoid arthritis patients.β-D-甘露糖醛酸治疗类风湿关节炎的国际多中心、随机、安慰剂对照 III 期临床试验。
Inflammopharmacology. 2019 Oct;27(5):911-921. doi: 10.1007/s10787-018-00557-2. Epub 2019 Jan 2.

本文引用的文献

1
Rapid radiological progression in the first year of early rheumatoid arthritis is predictive of disability and joint damage progression during 8 years of follow-up.早期类风湿关节炎发病第一年的快速放射学进展可预测 8 年随访期间的残疾和关节损伤进展。
Ann Rheum Dis. 2012 Sep;71(9):1530-3. doi: 10.1136/annrheumdis-2011-201212. Epub 2012 Apr 24.
2
How does age at onset influence the outcome of autoimmune diseases?发病年龄如何影响自身免疫性疾病的结局?
Autoimmune Dis. 2012;2012:251730. doi: 10.1155/2012/251730. Epub 2011 Dec 13.
3
The pathogenesis of rheumatoid arthritis.
类风湿关节炎的发病机制。
N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965.
4
Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: results from the Norfolk Arthritis Register.年龄和性别对近期发病的炎性多关节炎患者队列随时间推移的功能结局的影响:来自诺福克关节炎登记处的结果。
Arthritis Care Res (Hoboken). 2011 Dec;63(12):1745-52. doi: 10.1002/acr.20609.
5
Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS.类风湿关节炎的持续临床缓解:常规 DMARDs 治疗的患者队列中的患病率和预后因素。
Rheumatology (Oxford). 2012 Jan;51(1):169-75. doi: 10.1093/rheumatology/ker250. Epub 2011 Nov 16.
6
In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.在早期类风湿关节炎中,对甲氨蝶呤初始反应良好的患者具有极佳的 2 年临床结局,但并不能完全预防影像学进展:来自 SWEFOT 试验中甲氨蝶呤应答者人群的数据。
Ann Rheum Dis. 2012 Feb;71(2):186-91. doi: 10.1136/annrheumdis-2011-200038. Epub 2011 Sep 19.
7
Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria.以 IIIb 期 TAMARA 研究为例,评估新型 2011 年 ACR/EULAR 缓解标准在托珠单抗治疗中的表现,并与传统缓解标准进行比较。
Ann Rheum Dis. 2011 Nov;70(11):1986-90. doi: 10.1136/ard.2011.152678. Epub 2011 Aug 29.
8
Rheumatoid factor and antibodies against citrullinated peptides in Moroccan patients with rheumatoid arthritis: association with disease parameters and quality of life.类风湿因子和抗瓜氨酸化肽抗体在摩洛哥类风湿关节炎患者中的表达:与疾病参数和生活质量的关系。
Clin Rheumatol. 2012 Feb;31(2):329-34. doi: 10.1007/s10067-011-1820-4. Epub 2011 Aug 4.
9
Relationship between time-integrated disease activity estimated by DAS28-CRP and radiographic progression of anatomical damage in patients with early rheumatoid arthritis.DAS28-CRP 估计的疾病活动时间积分与早期类风湿关节炎患者解剖结构损伤进展的关系。
BMC Musculoskelet Disord. 2011 May 30;12:120. doi: 10.1186/1471-2474-12-120.
10
Treatment strategies in recent onset rheumatoid arthritis.近期发作类风湿关节炎的治疗策略。
Curr Opin Rheumatol. 2011 May;23(3):241-4. doi: 10.1097/BOR.0b013e3283454111.